Kenneth Crawford

Title: Kenneth Crawford: Innovator in Biotechnology

Introduction

Kenneth Crawford is a notable inventor based in Alameda, CA (US), recognized for his contributions to biotechnology. He holds 4 patents that reflect his innovative work in the field. His inventions focus on enhancing biological processes and improving the efficacy of therapeutic compositions.

Latest Patents

One of Kenneth's latest patents involves KGF polypeptide compositions. These compositions comprise keratinocyte growth factor (KGF) polypeptides and methods of using them. The KGF polypeptides described in this patent display enhanced bioactivity compared to full-length KGF. This advancement allows for the use of KGF polypeptides in lesser amounts than would be necessary with full-length KGF. Another significant patent addresses iron regulation of the PpSEC10 transcriptional regulatory region of Pichia pastoris. This patent provides methods and compositions for the expression of nucleotide sequences, utilizing the nucleic acid sequences of the transcriptional regulatory region of the PpSEC10 gene. The methods enable the regulation of polypeptide expression, particularly in yeast host cells.

Career Highlights

Kenneth Crawford has made significant strides in his career, particularly through his work at Chiron Corporation. His innovative approaches have contributed to advancements in biotechnology and therapeutic applications. His expertise in the field has positioned him as a valuable asset in the industry.

Collaborations

Kenneth has collaborated with notable colleagues, including Robert J Bishop and Isabel Zaror. These partnerships have fostered a collaborative environment that encourages innovation and the development of groundbreaking technologies.

Conclusion

Kenneth Crawford's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in therapeutic compositions and biological processes.